ABSTRACT Five patients had asthma provoked by cyanoacrylates and one by methyl methacrylate, possibly because of the development of a specific hypersensivity response. Acrylates have wide domestic as well as industrial uses, and inhalation of vapour emitted during their use can cause asthma.
Acrylates are widely used in the manufacture of adhesives, solvents, acrylic resins, and thermoplastics. Cyanoacrylate based glues give a high bond strength between a variety of materials and are available for domestic use as Superglue and for surgical use as tissue adhesives.' Methacrylates, which are chemically distinct from cyanoacrylates, serve as bases for acrylic resins, which have various applications, including use as adhesives and fillers in dental and orthopaedic procedures.23 Workers in pathology laboratories may be exposed as a result of their use in the plastic embedding of histological specimens.
Low molecular weight acrylic monomers are irritant to the eyes and mucous membranes, and have been reported to produce dermatitis4 and pulmonary oedema,5 but there is no previous report of an association with asthma. We report five cases of asthma occurring in association with exposure to cyanoacrylate based adhesives, and one case occurring in relation to exposure to methyl methacrylate. In each case, inhalation testing that mimicked exposure at work6 provoked an asthmatic reaction.
Methods
In patients 2 and 3 histamine reactivity was measured by a modification of the method of de Vries. PATIENT 4 A 46 year old woman worked in a factory assembling lampshades for four months without developing respiratory symptoms. Three weeks after starting to use an ethyl cyanoacrylate adhesive she developed episodes of cough and shortness of breath. Her cough became continuous and she began to wheeze, particularly at night. One week after she had stopped being exposed at work-single blind inhalation testing with cyanoacrylate glue produced symptoms of rhinitis and an immediate fall in peak expiratory flow (PEF) of 21%. This resolved, but there followed a progressive non-immediate fall, reaching a maximum seven hours afte'r the test of 64% below the pretest value (table). Exposure to a non-cyanoacrylate glue on a control day produced no asthmatic reaction. Skinprick tests with common inhalant allergens gave negative results. PATIENT 
5
A 24 year old woman worked in the same factory as patient 4 . Two weeks after starting to use an ethyl cyanoacrylate adhesive she developed symptoms of rhinitis and also nocturnal cough and wheeze that improved at weekends. She changed her occupation at work to avoid--further exposure,a'nd two m'onth's PATIENT 6 A 40 year old dental assistant mixed polymethyl methacrylate powder with monomethyl methacrylate liquid to produce a paste used in the manufacture of dental prosthetic trays. After several years of this work he began to experience chest tightness, dyspnoea, and cough, which persisted for several hours after exposure to even small amounts of methyl methacrylate. He gave no history of wheeze or difficulty breathing other than during the episodes at work, and had never been unduly short of breath on exertion. Two weeks after his last exposure at work he underwent inhalation testing in hospital. He mixed methyl methacrylate monomer and polymer, as at work, for 20 minutes. This provoked a fall in PEF of 24%, which resolved over two hours. The test was repeated one week later and provoked a similar immediate asthmatic reaction. No formal control test was made; but serial measurements of peak flow during the week between the two tests varied by less than 10% around 600 litres per minute, except for a morning dip to 500 litres per minute on waking, which improved spontaneously to 600 litres per minute by 12 midday, the time of the inhalation tests. He has had no recurrence of his asthma during this period. PATIENT 
7
A 52 year old railway cable joiner, who had smoked cigarettes for many years, used an acrylic cold curing resin system containing methyl methacrylate. He developed symptoms of headache, sweating, and lassitude, which occurred in relation to working with the resin system. Although he later developed frequent attacks of cough and wheeze, these respiratory symptoms were not clearly work related. No fall in FEV, followed inhalation challenge with histamine but serial recordings of peak expiratory flow rate indicated asthma. No asthmatic reaction followed single blind inhalation testing using the resin or control system (table). Skinprick tests with common inhalant allergens gave negative results.
Discussion
Our findings suggest that in five patients reported here cyanoacrylates are a primary cause of asthma and not acting as a non-specific provocative stimulus in individuals with hyperreactive airways. Each of the five patients who worked with cyanoacrylates had an initial symptom free period of exposure. None of the three tested with histamine showed increased responsiveness before their inhalation tests with cyanoacrylates and these inhalation tests provoked a non-immediate asthmatic reaction in all three. Airway reactivity increases after nonimmediate asthmatic reactionse and decreases with avoidance of exposure to its inducing cause.'0 Each of these three patients had avoided or reduced their exposure to cyanoacrylates before inhalation testing, which probably explains the absence of increased airway reactivity before the tests. We did not repeat the histamine tests after the inhalation tests with cyanoacrylates, but possibly airway reactivity would have increased after the late asthmatic reactions.
Cyanoacrylate adhesives were introduced for 
